Company intelligence / Profile preview
Adamed Pharma
Ksawerów, Łódź, Polandadamed.com ↗
- Ownership
- Private
- Employees
- ~1800
- Development stage
- Commercial
01
Overview
Adamed has a broad commercial portfolio (~900 products/SKUs) across 19 therapeutic areas with global sales in over 70 countries. Its innovative pipeline includes small molecules and biologics targeting oncology and CNS indications. The company has successfully licensed out at least one CNS drug candidate and advanced several proprietary molecules to the clinical trial transfer stage.
- Therapeutic areas
- OncologyMetabolic DisordersPsychiatryCardiovascularInfectious Diseases
- Modalities
- Small moleculesrecombinant fusion proteinsgenerics
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Ecupharma S.r.l. (Italy)Jagiellonian University consortiumMIT Enterprise Forum CEE partnervarious academic collaborations.
Beyond the preview
Go deeper on Adamed Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adamed Pharma.